MEIP logo

MEI Pharma (MEIP) Cash From Operations

Annual CFO

-$50.47 M
+$2.01 M+3.83%

June 30, 2024

Summary

Performance

1-Year Change

+3.83%

3-Year Change

-57.91%

5-Year Change

-71.54%

15-Year Change

-1547.88%

MEIP Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

26.94%
MEIP annual cash flow from operations is higher than 26.94% of companies in Healthcare sector

High & Low

All-time High

$34.26 M
MEIP annual cash flow from operations is currently -247.33% below its historical high of $34.26 million

3-Year Low

-$52.48 M

Earnings dates

Last Annual Earnings Report Date

Jun 30, 2024
MEIP previous annual earnings announcement was published on Jun 30, 2024

Next Annual Earnings Report Date

N/A
MEIP next annual earnings announcement has not yet been scheduled

OtherMEIPcash flowmetrics:

Annual CFI

$49.14 M
MEIP annual cash flow from investing activities is $49.14 million

Annual CFF

-$11.87 M
MEIP annual cash flow from financing activities is -$11.87 million

Annual FCF

-$50.48 M
MEIP annual free cash flow is -$50.48 million

Annual CAPEX

$7000.00
MEIP annual capital expenditures is $7000.00

Quarterly CFO

-$11.45 M
+$6.55 M+36.39%

September 30, 2024

Summary

Performance

3-Month Change

+36.39%

1-Year Change

-291.05%

3-Year Change

-291.05%

5-Year Change

-291.05%

MEIP Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

29.26%
MEIP quarterly cash flow from operations is higher than 29.26% of companies in Healthcare sector

High & Low

All-time High

$69.11 M
MEIP quarterly cash flow from operations is currently -116.57% below its historical high of $69.11 million

3-Year Low

-$18.49 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MEIP previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
MEIP next earnings announcement is scheduled for Feb 13, 2025

OtherMEIPcash flowmetrics:

Quarterly CFI

$14.70 M
MEIP quarterly cash flow from investing activities is $14.70 million

Quarterly CFF

-
MEIP quarterly cash flow from financing activities value is unknown

Quarterly FCF

-$11.45 M
MEIP quarterly free cash flow is -$11.45 million

Quarterly CAPEX

-
MEIP quarterly capital expenditures value is unknown

TTM CFO

-$43.43 M
+$7.04 M+13.95%

September 30, 2024

Summary

Performance

3-Month Change

+13.95%

1-Year Change

+0.79%

3-Year Change

+0.79%

5-Year Change

+0.79%

MEIP TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

31.27%
MEIP TTM cash flow from operations is higher than 31.27% of companies in Healthcare sector

High & Low

All-time High

$53.76 M
MEIP TTM cash flow from operations is currently -180.79% below its historical high of $53.76 million

3-Year Low

-$61.51 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MEIP previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
MEIP next earnings announcement is scheduled for Feb 13, 2025

OtherMEIPcash flowmetrics:

TTM CFI

$58.88 M
MEIP TTM cash flow from investing activities is $58.88 million

TTM CFF

-
MEIP TTM cash flow from financing activities value is unknown

TTM FCF

-$43.44 M
MEIP TTM free cash flow is -$43.44 million

TTM CAPEX

-
MEIP TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

MEIP Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3.8%-291.1%+0.8%
3 y3 years-57.9%-291.1%+0.8%
5 y5 years-71.5%-291.1%+0.8%

MEIP Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-57.9%+3.8%-291.1%+38.1%-0.6%+29.4%
5 y5-year-247.3%+3.8%-116.6%+38.1%-180.8%+29.4%
alltimeall time-247.3%+3.8%-116.6%+38.1%-180.8%+29.4%

MEI Pharma Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$11.45 M(-36.4%)
-$43.43 M(-14.0%)
Jun 2024
-$50.47 M(-3.8%)
-$18.00 M(+514.7%)
-$50.47 M(+15.3%)
Mar 2024
-
-$2.93 M(-73.5%)
-$43.78 M(-17.4%)
Dec 2023
-
-$11.05 M(-40.2%)
-$52.98 M(-5.7%)
Sep 2023
-
-$18.49 M(+63.6%)
-$56.19 M(+7.1%)
Jun 2023
-$52.48 M(+7.7%)
-$11.30 M(-6.8%)
-$52.48 M(-7.4%)
Mar 2023
-
-$12.13 M(-15.0%)
-$56.69 M(-7.8%)
Dec 2022
-
-$14.27 M(-3.5%)
-$61.51 M(+10.2%)
Sep 2022
-
-$14.78 M(-4.7%)
-$55.81 M(+14.5%)
Jun 2022
-$48.75 M(+52.5%)
-$15.50 M(-8.6%)
-$48.75 M(+9.5%)
Mar 2022
-
-$16.95 M(+97.9%)
-$44.50 M(+3.0%)
Dec 2021
-
-$8.57 M(+10.9%)
-$43.19 M(+41.3%)
Sep 2021
-
-$7.72 M(-31.4%)
-$30.57 M(-4.3%)
Jun 2021
-$31.96 M(-193.3%)
-$11.26 M(-28.1%)
-$31.96 M(-166.0%)
Mar 2021
-
-$15.65 M(-486.3%)
$48.41 M(-10.0%)
Dec 2020
-
$4.05 M(-144.5%)
$53.76 M(+37.0%)
Sep 2020
-
-$9.11 M(-113.2%)
$39.23 M(+14.5%)
Jun 2020
$34.26 M(-216.4%)
$69.11 M(-771.3%)
$34.26 M(-179.8%)
Mar 2020
-
-$10.29 M(-1.8%)
-$42.92 M(-2.4%)
Dec 2019
-
-$10.48 M(-25.6%)
-$43.97 M(+43.3%)
Sep 2019
-
-$14.08 M(+74.6%)
-$30.68 M(+4.3%)
Jun 2019
-$29.42 M(+39.9%)
-$8.06 M(-28.9%)
-$29.42 M(+18.4%)
Mar 2019
-
-$11.34 M(-505.2%)
-$24.84 M(+25.9%)
Dec 2018
-
$2.80 M(-121.8%)
-$19.74 M(-27.7%)
Sep 2018
-
-$12.82 M(+268.0%)
-$27.29 M(+29.7%)
Jun 2018
-$21.04 M(-703.4%)
-$3.48 M(-44.2%)
-$21.04 M(+1.6%)
Mar 2018
-
-$6.24 M(+31.3%)
-$20.70 M(+61.0%)
Dec 2017
-
-$4.75 M(-27.6%)
-$12.85 M(+8.5%)
Sep 2017
-
-$6.56 M(+108.6%)
-$11.85 M(-439.9%)
Jun 2017
$3.49 M(-119.5%)
-$3.15 M(-295.9%)
$3.49 M(+10.7%)
Mar 2017
-
$1.61 M(-142.9%)
$3.15 M(-210.8%)
Dec 2016
-
-$3.75 M(-142.7%)
-$2.84 M(-14.5%)
Sep 2016
-
$8.77 M(-351.9%)
-$3.32 M(-81.4%)
Jun 2016
-$17.86 M(-36.4%)
-$3.48 M(-20.6%)
-$17.86 M(-15.4%)
Mar 2016
-
-$4.38 M(+3.7%)
-$21.12 M(-15.1%)
Dec 2015
-
-$4.23 M(-26.6%)
-$24.88 M(-8.2%)
Sep 2015
-
-$5.76 M(-14.6%)
-$27.10 M(-3.5%)
Jun 2015
-$28.07 M(+44.3%)
-$6.74 M(-17.3%)
-$28.07 M(+3.3%)
Mar 2015
-
-$8.15 M(+26.4%)
-$27.18 M(+12.8%)
Dec 2014
-
-$6.45 M(-4.2%)
-$24.10 M(+9.0%)
Sep 2014
-
-$6.73 M(+15.1%)
-$22.12 M(+13.7%)
Jun 2014
-$19.45 M
-$5.85 M(+15.4%)
-$19.45 M(+18.8%)
Mar 2014
-
-$5.07 M(+13.5%)
-$16.37 M(+17.5%)
DateAnnualQuarterlyTTM
Dec 2013
-
-$4.47 M(+9.9%)
-$13.93 M(+19.9%)
Sep 2013
-
-$4.06 M(+46.9%)
-$11.62 M(+15.7%)
Jun 2013
-$10.04 M(+41.8%)
-$2.77 M(+5.1%)
-$10.04 M(+17.0%)
Mar 2013
-
-$2.63 M(+21.8%)
-$8.58 M(+4.4%)
Dec 2012
-
-$2.16 M(-13.1%)
-$8.22 M(+4.9%)
Sep 2012
-
-$2.49 M(+90.7%)
-$7.84 M(+10.7%)
Jun 2012
-$7.08 M(+8.9%)
-$1.30 M(-42.6%)
-$7.08 M(-4.5%)
Mar 2012
-
-$2.27 M(+28.1%)
-$7.41 M(+8.2%)
Dec 2011
-
-$1.77 M(+2.5%)
-$6.85 M(+1.8%)
Sep 2011
-
-$1.73 M(+5.9%)
-$6.73 M(+3.5%)
Jun 2011
-$6.50 M(-35.2%)
-$1.63 M(-4.5%)
-$6.50 M(-9.4%)
Mar 2011
-
-$1.71 M(+3.6%)
-$7.17 M(+3.4%)
Dec 2010
-
-$1.65 M(+9.8%)
-$6.94 M(-10.0%)
Sep 2010
-
-$1.50 M(-34.8%)
-$7.70 M(-23.2%)
Jun 2010
-$10.03 M(-4.9%)
-$2.31 M(+56.6%)
-$10.03 M(-15.1%)
Mar 2010
-
-$1.47 M(-39.1%)
-$11.81 M(-3.0%)
Dec 2009
-
-$2.42 M(-36.9%)
-$12.18 M(+4.4%)
Sep 2009
-
-$3.83 M(-6.1%)
-$11.66 M(+10.5%)
Jun 2009
-$10.55 M(-8.2%)
-$4.08 M(+122.4%)
-$10.55 M(+10.3%)
Mar 2009
-
-$1.84 M(-3.6%)
-$9.57 M(-15.7%)
Dec 2008
-
-$1.91 M(-30.1%)
-$11.35 M(-3.7%)
Sep 2008
-
-$2.73 M(-12.1%)
-$11.79 M(+2.6%)
Jun 2008
-$11.50 M(+6.6%)
-$3.10 M(-14.3%)
-$11.50 M(+9.7%)
Mar 2008
-
-$3.62 M(+54.0%)
-$10.48 M(+19.4%)
Dec 2007
-
-$2.35 M(-3.5%)
-$8.78 M(+23.7%)
Sep 2007
-
-$2.43 M(+16.5%)
-$7.10 M(-34.2%)
Jun 2007
-$10.79 M(+18.7%)
-$2.09 M(+9.2%)
-$10.79 M(-5.5%)
Mar 2007
-
-$1.91 M(+188.0%)
-$11.41 M(-20.6%)
Dec 2006
-
-$664.00 K(-89.2%)
-$14.37 M(-0.2%)
Sep 2006
-
-$6.12 M(+125.6%)
-$14.39 M(+58.4%)
Jun 2006
-$9.09 M(+62.9%)
-$2.71 M(-44.3%)
-$9.09 M(+23.4%)
Mar 2006
-
-$4.87 M(+609.2%)
-$7.37 M(+37.2%)
Dec 2005
-
-$687.00 K(-15.8%)
-$5.37 M(+0.2%)
Sep 2005
-
-$816.00 K(-17.8%)
-$5.36 M(-4.0%)
Jun 2005
-$5.58 M(-30.0%)
-$993.00 K(-65.5%)
-$5.58 M(+5.0%)
Mar 2005
-
-$2.88 M(+325.3%)
-$5.32 M(-35.2%)
Dec 2004
-
-$676.00 K(-34.8%)
-$8.20 M(-0.7%)
Sep 2004
-
-$1.04 M(+42.4%)
-$8.26 M(+3.6%)
Jun 2004
-$7.97 M(+333.0%)
-$728.00 K(-87.4%)
-$7.97 M(+10.0%)
Mar 2004
-
-$5.76 M(+683.3%)
-$7.24 M(+387.2%)
Dec 2003
-
-$735.00 K(-2.3%)
-$1.49 M(+97.7%)
Sep 2003
-
-$752.00 K
-$752.00 K
Jun 2003
-$1.84 M
-
-

FAQ

  • What is MEI Pharma annual cash flow from operations?
  • What is the all time high annual CFO for MEI Pharma?
  • What is MEI Pharma annual CFO year-on-year change?
  • What is MEI Pharma quarterly cash flow from operations?
  • What is the all time high quarterly CFO for MEI Pharma?
  • What is MEI Pharma quarterly CFO year-on-year change?
  • What is MEI Pharma TTM cash flow from operations?
  • What is the all time high TTM CFO for MEI Pharma?
  • What is MEI Pharma TTM CFO year-on-year change?

What is MEI Pharma annual cash flow from operations?

The current annual CFO of MEIP is -$50.47 M

What is the all time high annual CFO for MEI Pharma?

MEI Pharma all-time high annual cash flow from operations is $34.26 M

What is MEI Pharma annual CFO year-on-year change?

Over the past year, MEIP annual cash flow from operations has changed by +$2.01 M (+3.83%)

What is MEI Pharma quarterly cash flow from operations?

The current quarterly CFO of MEIP is -$11.45 M

What is the all time high quarterly CFO for MEI Pharma?

MEI Pharma all-time high quarterly cash flow from operations is $69.11 M

What is MEI Pharma quarterly CFO year-on-year change?

Over the past year, MEIP quarterly cash flow from operations has changed by -$8.52 M (-291.05%)

What is MEI Pharma TTM cash flow from operations?

The current TTM CFO of MEIP is -$43.43 M

What is the all time high TTM CFO for MEI Pharma?

MEI Pharma all-time high TTM cash flow from operations is $53.76 M

What is MEI Pharma TTM CFO year-on-year change?

Over the past year, MEIP TTM cash flow from operations has changed by +$344.00 K (+0.79%)